Ott Scientific Acquires American Bionostica
April 1, 2021
Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.
- Buyers
- Ott Scientific
- Targets
- American Bionostica, Inc.
- Industry
- Medical Devices
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
VION Biosciences Acquires BioAssay Systems
February 5, 2025
Biotechnology
VION Biosciences acquired Hayward, California–based BioAssay Systems in January 2025 as the fourth add-on for its life‑science products platform. The deal adds BioAssay Systems’ enzymatic and high‑throughput assay kits, reagents and analytical services to VION’s proprietary product portfolio to accelerate capability expansion for drug discovery and life‑science research customers.
-
Optibrium Acquires BioPharmics LLC
August 31, 2023
Software
Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.
-
Asahi Kasei Medical to Acquire Bionova Scientific
April 14, 2022
Healthcare Services
Asahi Kasei Medical, through a U.S. subsidiary, has agreed to wholly acquire Bionova Scientific, LLC, a U.S.-based biopharmaceutical CDMO providing contract process development and GMP-compliant contract manufacturing services. The acquisition will add CDMO capabilities to Asahi Kasei Medical’s existing bioprocess business and broaden know-how-driven services for next-generation antibody drugs.
-
Bionano Genomics Acquires BioDiscovery
October 12, 2021
Software
Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.
-
Heska Corporation Acquires Biotech Laboratories U.S.A. LLC to Enter Rapid Assay Veterinary Diagnostics Market
September 1, 2021
Medical Devices
Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.
-
Abenex Acquires Cisbio Bioassays from Argos Soditic
June 16, 2016
Biotechnology
French private equity firm Abenex has acquired Cisbio Bioassays from seller Argos Soditic. Abenex will partner with the biotech to support its organic and external growth strategy across pharmaceutical research and in vitro diagnostics; Cisbio has ~210 employees and generates over 85% of revenue outside France.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.